Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in ...
LS1Tech6d
GM Recalls 90K Cadillac CTx & 6th Gen Camaros Over Trans Lock-Up Risk – What You Should Know
GM has notified dealers about the recall as of March 6, 2025, and plans to begin notifying owners on April 21, 2025. Owners ...
Business Insider26d
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2 CTx-1301 is the First, True, Once-Daily Stimulant Medication to Treat ADHD Over the Entire Active Day KANSAS CITY, Kan.
pharmaphorum1mon
FDA clears first therapy for rare disease CTX from Mirum
Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form of lipid storage disease. Ctexli (chenodiol) has been cleared to treat ...
Nasdaq26d
Cingulate Inc. Submits Phase 3 Safety Data for CTx-1301 Ahead of FDA Meeting on ADHD Treatment
Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025. Cingulate Inc. announced the submission of Phase 3 safety data for its ADHD ...
Mirage News11d
FDA OKs Drug for Rare Genetic Disorder, Offers Hope
OHSU's pioneering research, clinical trials led to better testing, approval for CTX disease Eric Stewart has a rare disease ...
Business Insider1mon
Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
Top-line Phase 2/3 data readout for COMPANION-002, evaluating tovecimig (CTX-009 - a DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer (BTC), is on track for the end of the ...
Linux Journal4y
Listing 2. Using sigcontext
#include <stdio.h> #include <signal.h> #include <execinfo.h> void bt_sighandler(int sig, struct sigcontext ctx) { void *trace[16]; char **messages = (char **)NULL ...